TY - JOUR
T1 - Anisotropic Materials for Skeletal-Muscle-Tissue Engineering
AU - Jana, Soumen
AU - Levengood, Sheeny K.Lan
AU - Zhang, Miqin
N1 - Funding Information:
S.J. and S.K.L.L. contributed equally to this work. This work was supported in part by NIH grant R01CA172455, Washington Research Foundation gift, and Kyocera Professorship Endowment (Professor Miqin Zhang). S.K.L.L. acknowledges support from a Ruth L. Kirschstein NIH training grant T32CA138312.
Publisher Copyright:
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
PY - 2016/12/28
Y1 - 2016/12/28
N2 - Repair of damaged skeletal-muscle tissue is limited by the regenerative capacity of the native tissue. Current clinical approaches are not optimal for the treatment of large volumetric skeletal-muscle loss. As an alternative, tissue engineering represents a promising approach for the functional restoration of damaged muscle tissue. A typical tissue-engineering process involves the design and fabrication of a scaffold that closely mimics the native skeletal-muscle extracellular matrix (ECM), allowing organization of cells into a physiologically relevant 3D architecture. In particular, anisotropic materials that mimic the morphology of the native skeletal-muscle ECM, can be fabricated using various biocompatible materials to guide cell alignment, elongation, proliferation, and differentiation into myotubes. Here, an overview of fundamental concepts associated with muscle-tissue engineering and the current status of muscle-tissue-engineering approaches is provided. Recent advances in the development of anisotropic scaffolds with micro- or nanoscale features are reviewed, and how scaffold topographical, mechanical, and biochemical cues correlate to observed cellular function and phenotype development is examined. Finally, some recent developments in both the design and utility of anisotropic materials in skeletal-muscle-tissue engineering are highlighted, along with their potential impact on future research and clinical applications.
AB - Repair of damaged skeletal-muscle tissue is limited by the regenerative capacity of the native tissue. Current clinical approaches are not optimal for the treatment of large volumetric skeletal-muscle loss. As an alternative, tissue engineering represents a promising approach for the functional restoration of damaged muscle tissue. A typical tissue-engineering process involves the design and fabrication of a scaffold that closely mimics the native skeletal-muscle extracellular matrix (ECM), allowing organization of cells into a physiologically relevant 3D architecture. In particular, anisotropic materials that mimic the morphology of the native skeletal-muscle ECM, can be fabricated using various biocompatible materials to guide cell alignment, elongation, proliferation, and differentiation into myotubes. Here, an overview of fundamental concepts associated with muscle-tissue engineering and the current status of muscle-tissue-engineering approaches is provided. Recent advances in the development of anisotropic scaffolds with micro- or nanoscale features are reviewed, and how scaffold topographical, mechanical, and biochemical cues correlate to observed cellular function and phenotype development is examined. Finally, some recent developments in both the design and utility of anisotropic materials in skeletal-muscle-tissue engineering are highlighted, along with their potential impact on future research and clinical applications.
KW - anisotropic materials
KW - micropatterned substrates
KW - muscles
KW - nanofibers
KW - scaffolds
KW - tissue engineering
UR - http://www.scopus.com/inward/record.url?scp=85003520655&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85003520655&partnerID=8YFLogxK
U2 - 10.1002/adma.201600240
DO - 10.1002/adma.201600240
M3 - Review article
C2 - 27865007
AN - SCOPUS:85003520655
SN - 0935-9648
VL - 28
SP - 10588
EP - 10612
JO - Advanced Materials
JF - Advanced Materials
IS - 48
ER -